Skip to main content
MedPath Trial logoMedPath TrialMedPath Trial Home
Clinical Trials/EUCTR2015-003250-41-GB
EUCTR2015-003250-41-GBActive, not recruitingPhase 1

Protection induced by Live Attenuated Influenza Vaccine (LAIV or Fluenz Tetra) - applied epidemiological study - LAIV PROTECT

Public Health England0 sites2,500 target enrollmentStarted: February 8, 2019Last updated:
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
Drugs

Trial Snapshot

Phase
Phase 1
Status
Active, not recruiting
Enrollment
2,500
Study OverviewEligibility CriteriaInvestigatorsRecords & IdentifiersSimilar Trials

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional clinical trial of medicinal product

Eligibility Criteria

Inclusion Criteria

  • •- Healthy children aged 10 to 16 (born between 1/9/2005 and 1/9/1999) or staff at the participating school sites of any age
  • •- Children must be enrolled and attending one of the two schools study sites in the 2015/16 school year.
  • •- Staff must be working at one of the 2 school study sites in the 2015/16 school year.
  • •- Relevant consent, parental/guardian consent and participant assent or participant consent (age dependant)
  • •Are the trial subjects under 18? yes
  • •Number of subjects for this age range: 0
  • •F.1.2 Adults (18-64 years) yes
  • •F.1.2.1 Number of subjects for this age range 0
  • •F.1.3 Elderly (>=65 years) no
  • •F.1.3.1 Number of subjects for this age range 0

Exclusion Criteria

  • •- Any current or previous condition/circumstance that, in the opinion of the investigator, may put the individual at risk if participating in the study

Investigators

Similar Trials

Active, not recruiting
Phase 1
The Effect of Live Attenuated Influenza Vaccine (LAIV) on Experimental Human Pneumococcal Colonisation (EHPC) StudyPneumococcal colonisation post inoculationMedDRA version: 18.1 Level: PT Classification code 10059429 Term: Influenza immunisation System Organ Class: 10042613 - Surgical and medical procedures
EUCTR2014-004634-26-GBRoyal Liverpool University Hospital335
Not yet recruiting
Not Applicable
Examination of protective efficacy of influenza by zanamivir among the staff of a medical facilityinfluenza
JPRN-UMIN000012799Shizuoka Kosei Hospital100
Not yet recruiting
Not Applicable
Examination of protective efficacy of influenza by zanamivir among the staff of a medical facility: the 2nd trialInfluenza
JPRN-UMIN000016200Shizuoka Kosei Hosipital100
Completed
Phase 4
The Effect of Live Attenuated Inactivated Influenza Vaccine on Experimental Human Pneumococcal Carriage StudyInfluenza, HumanPneumonia
NCT03502291Liverpool University Hospitals NHS Foundation Trust324
Completed
Not Applicable
Influenza viral shedding after treatment with and anti-influenza drugInfluenza
JPRN-UMIN000046233Japan Physicians Association Influenza Study Group200